Skip to content

Two generic versions of nevirapine approved for PEPFAR use

Duration of ddI treatment and dose risk factors for CD4 loss in patients taking ddI/tenofovir

Lipid-lowering drugs better at lowering blood fats caused by protease inhibitors than switching to NNRTI

Once daily Kaletra: dose escalation rarely the answer for those with low plasma levels

Meeting men on the internet not associated with unprotected sex, says Dutch study

Cotrimoxazole prophylaxis for people with HIV reduces illness and death in other family members too

South African HIV prevalence steadily rising; researchers investigate why some communities are harder hit

Lipid-lowering drugs more effective than switch to NNRTI in managing lipid elevations

Replacement of protease inhibitor results in improved blood fat levels, but doesn't stop fat loss